INS and type 1 diabetes mellitus: A randomized, double-blind, placebo-controlled phase 2 clinical trial (NCT04545151), along with testing insulin intake, is also currently recruiting, with the aim to confirm the effect of 360 mg of oral administration of verapamil alone and in combination with other drugs among participants with newly diagnosed T1D.